Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Laninamivir> ?p ?o }
Showing triples 1 to 82 of
82
with 100 triples per page.
- Laninamivir abstract "Laninamivir (CS-8958) is a neuraminidase inhibitor which is being researched for the treatment and prophylaxis of Influenzavirus A and Influenzavirus B. It is currently in Phase III clinical trials. It is a long-acting neuraminidase inhibitor administered by nasal inhalation.Laninamivir was approved for influenza treatment in Japan in 2010 and for prophylaxis in 2013. It is currently marketed under the name Inavir by Daiichi Sankyo. Biota Pharmaceuticals and Daiichi Sankyo co-own Laninamivir. On 1 April 2011, BARDA awarded up to an estimated U$231m to Biota Pharmaceuticals (Formerly Biota Holdings Ltd) wholly owned subsidiary, Biota Scientific Management Pty Ltd, for the advanced development of Laninamivir in the US. It is under clinical evaluations in other countries.".
- Laninamivir atcPrefix "none".
- Laninamivir casNumber "203120-17-6".
- Laninamivir fdaUniiCode "B408IW3GL5".
- Laninamivir iupacName "(4S,5R,6R)-5-acetamido-4-carbamimidamido-6-[(1R,2R)-3-hydroxy-2-methoxypropyl]-5,6-dihydro-4H-pyran-2-carboxylic acid".
- Laninamivir pubchem "502272".
- Laninamivir thumbnail Laninamivir.svg?width=300.
- Laninamivir wikiPageID "23927032".
- Laninamivir wikiPageLength "3600".
- Laninamivir wikiPageOutDegree "8".
- Laninamivir wikiPageRevisionID "704250753".
- Laninamivir wikiPageWikiLink Category:Acetamides.
- Laninamivir wikiPageWikiLink Category:Dihydropyrans.
- Laninamivir wikiPageWikiLink Category:Guanidines.
- Laninamivir wikiPageWikiLink Category:Neuraminidase_inhibitors.
- Laninamivir wikiPageWikiLink Influenza_A_virus.
- Laninamivir wikiPageWikiLink Influenzavirus_B.
- Laninamivir wikiPageWikiLink Neuraminidase_inhibitor.
- Laninamivir wikiPageWikiLink Preventive_healthcare.
- Laninamivir wikiPageWikiLinkText "Laninamivir".
- Laninamivir atcPrefix "none".
- Laninamivir c "13".
- Laninamivir casNumber "203120".
- Laninamivir chembl "466246".
- Laninamivir chemspiderid "439182".
- Laninamivir h "22".
- Laninamivir inchi "1".
- Laninamivir inchikey "QNRRHYPPQFELSF-CNYIRLTGBV".
- Laninamivir iupacName "-5".
- Laninamivir molecularWeight "346.33638".
- Laninamivir n "4".
- Laninamivir o "7".
- Laninamivir pubchem "502272".
- Laninamivir routesOfAdministration "Inhalation".
- Laninamivir smiles "O=CC=1O[C@@H][C@H][C@@H]C=1".
- Laninamivir stdinchi "1".
- Laninamivir stdinchikey "QNRRHYPPQFELSF-CNYIRLTGSA-N".
- Laninamivir unii "B408IW3GL5".
- Laninamivir verifiedfields "changed".
- Laninamivir verifiedrevid "462088695".
- Laninamivir width "200".
- Laninamivir wikiPageUsesTemplate Template:Antiinfective-drug-stub.
- Laninamivir wikiPageUsesTemplate Template:Cascite.
- Laninamivir wikiPageUsesTemplate Template:Chemspidercite.
- Laninamivir wikiPageUsesTemplate Template:Drugbankcite.
- Laninamivir wikiPageUsesTemplate Template:Drugbox.
- Laninamivir wikiPageUsesTemplate Template:Ebicite.
- Laninamivir wikiPageUsesTemplate Template:Fdacite.
- Laninamivir wikiPageUsesTemplate Template:Influenza.
- Laninamivir wikiPageUsesTemplate Template:RNA_antivirals.
- Laninamivir wikiPageUsesTemplate Template:Reflist.
- Laninamivir wikiPageUsesTemplate Template:Stdinchicite.
- Laninamivir subject Category:Acetamides.
- Laninamivir subject Category:Dihydropyrans.
- Laninamivir subject Category:Guanidines.
- Laninamivir subject Category:Neuraminidase_inhibitors.
- Laninamivir hypernym Inhibitor.
- Laninamivir type Agent.
- Laninamivir type ChemicalSubstance.
- Laninamivir type Drug.
- Laninamivir type Agent.
- Laninamivir type Amide.
- Laninamivir type Chemical.
- Laninamivir type Drug.
- Laninamivir type Heterocycle.
- Laninamivir type Inhibitor.
- Laninamivir type ChemicalObject.
- Laninamivir type Thing.
- Laninamivir type Q8386.
- Laninamivir comment "Laninamivir (CS-8958) is a neuraminidase inhibitor which is being researched for the treatment and prophylaxis of Influenzavirus A and Influenzavirus B. It is currently in Phase III clinical trials. It is a long-acting neuraminidase inhibitor administered by nasal inhalation.Laninamivir was approved for influenza treatment in Japan in 2010 and for prophylaxis in 2013. It is currently marketed under the name Inavir by Daiichi Sankyo. Biota Pharmaceuticals and Daiichi Sankyo co-own Laninamivir.".
- Laninamivir label "Laninamivir".
- Laninamivir sameAs Q6487096.
- Laninamivir sameAs Laninamivir.
- Laninamivir sameAs Laninamivir.
- Laninamivir sameAs ラニナミビル.
- Laninamivir sameAs m.076yyn_.
- Laninamivir sameAs Laninamivir.
- Laninamivir sameAs Laninamivir.
- Laninamivir sameAs Q6487096.
- Laninamivir wasDerivedFrom Laninamivir?oldid=704250753.
- Laninamivir depiction Laninamivir.svg.
- Laninamivir isPrimaryTopicOf Laninamivir.